ArticleClinical ophthalmology (Auckland, N.Z.)2019

Real world use of loteprednol etabonate ophthalmic gel 0.5% in cases representative of comorbid pathologies responding to minimally invasive glaucoma surgery.

J D Sheppard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.